Haleon (HLN) Amortizatization of Intangibles (2022 - 2023)

Haleon (HLN) posted Amortizatization of Intangibles of $67.0 million for Q4 2023, up 14.28% on a QoQ basis from $58.6 million in Q4 2022, and up 14.28% year-over-year from $58.6 million in Q4 2022.

Haleon (HLN) Amortizatization of Intangibles (2022 - 2023) Analysis & Trends

Haleon's Amortizatization of Intangibles history runs 2 years deep, the most recent figure standing at $67.0 million for Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn -
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn -
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn -
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 1.30 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn -
10 Vireo Growth 10.53 Bn 10.38 Bn 59.30 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 67.02 Mn
Dec 31, 2023 67.02 Mn
Dec 31, 2022 58.65 Mn
Dec 31, 2022 58.65 Mn